Pure red blood cell aplasia and isoniazid use [3]

Emerging Infectious Diseases

Volumn 13, Issue 9, 2007, Pages 1427-1428

  Loulergue, Pierre ^a   Mir, Olivier ^b,d   Dhote, Robin ^c  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b Institut Cochin   (France)

^c AVICENNE HOSPITAL   (France)

^d Service de Médecine Interne   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

AGED; AUTOIMMUNE HEMOLYTIC ANEMIA; BONE MARROW BIOPSY; CASE REPORT; DRUG EXPOSURE; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; EOSINOPHILIA; ERYTHROCYTE APLASIA; FEMALE; GASTROINTESTINAL SYMPTOM; HEMOGLOBIN DETERMINATION; HEPATITIS; HUMAN; LETTER; LUNG TUBERCULOSIS; MEGAKARYOCYTE; PERIPHERAL NEUROPATHY; RASH; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 34848837735     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1309.061334     Document Type: Letter

References (5)

1. Goldman AL, Braman SS. Isoniazid: a review with emphasis on adverse effects. Chest. 1972;62:71-7.
2. Fisch P, Handgretinger R, Schaefer HE. Pure red cell aplasia. Br J Haematol. 2000;111:1010-22.
3. Goodman SB, Block MH. A case of red cell aplasia occurring as a result of antituberculous therapy. Blood. 1964;24:616-23.
4. Sen R, Singh U, Yadav MS, Raj B, Sen J. Isoniazid induced pure red cell aplasia. Ind J Tuberc. 1989;36:41-3.
5. Dixit R, Dixit R, Dixit K. Isoniazid induced pure red cell aplasia. Indian Journal of Allergy Asthma and Immunology. 2003;17:93-5.